Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:766-770

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gosse, P.
Right arrow Articles by Clementy, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gosse, P.
Right arrow Articles by Clementy, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure

Hypertension, Vol 22, 766-770, Copyright © 1993 by American Heart Association


ARTICLES

'White coat' hypertension. No harm for the heart

P Gosse, H Promax, P Durandet and J Clementy
Hopital Cardiologique, Pessac, France.

The superiority of ambulatory blood pressure monitoring over casual blood pressure measurement for the prediction of target-organ damage is now well established, although the significance of "white coat" hypertension is still controversial. Is an office blood pressure measurement that is higher than the mean ambulatory value an added risk? Because left ventricular hypertrophy is a potent risk factor, the effect of hypertension on left ventricular mass merits attention. Left ventricular mass indexed for height was measured by M-mode echocardiography in 204 essential hypertensive patients (140 males, 64 females; mean age [SD], 50 [11] years). Blood pressure over 24 hours was monitored routinely with a noninvasive auscultatory device. Office blood pressure after 10 minutes of the subject in the supine position was measured by the same physician under the same conditions. The white coat effect was defined as the difference between the office and average daytime values of systolic and diastolic blood pressures. Patients were divided into four quartiles according to their office and daytime blood pressures. Two-way analysis of variance was used to assess the influence of the white coat effect at a given level of daytime blood pressure on left ventricular mass. Left ventricular mass increased significantly (P < .001) with daytime systolic blood pressure but was independent of white coat effect for both the whole population and the 143 untreated patients. We conclude that the white coat effect has no influence on left ventricular mass, favoring the view that white coat hypertension is a benign condition.


This article has been cited by other articles:


Home page
Vet Rec.Home page
S. Schellenberg, T. M. Glaus, and C. E. Reusch
Effect of long-term adaptation on indirect measurements of systolic blood pressure in conscious untrained beagles
Vet Rec., September 22, 2007; 161(12): 418 - 421.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. I. Chaudhry, H. M. Krumholz, and J. M. Foody
Systolic Hypertension in Older Persons
JAMA, September 1, 2004; 292(9): 1074 - 1080.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Gomez-Cerezo, J. J. Rios Blanco, I. Suarez Garcia, P. Moreno Anaya, P. Garcia Raya, E. Vazquez-Munoz, and F. J. Barbado Hernandez
Noninvasive Study of Endothelial Function in White Coat Hypertension
Hypertension, September 1, 2002; 40(3): 304 - 309.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. Smith, L. N. Graham, A. F. Mackintosh, J. B. Stoker, and D. A. S. G. Mary
Sympathetic neural mechanisms in white-coat hypertension
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 126 - 132.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Moser
White-Coat Hypertension--To Treat or Not to Treat: A Clinical Dilemma
Arch Intern Med, December 10, 2001; 161(22): 2655 - 2656.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. M. Grandi, R. Broggi, S. Colombo, R. Santillo, D. Imperiale, A. Bertolini, L. Guasti, and A. Venco
Left Ventricular Changes in Isolated Office Hypertension: A Blood Pressure-Matched Comparison With Normotension and Sustained Hypertension
Arch Intern Med, December 10, 2001; 161(22): 2677 - 2681.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
G. Bobrie, N. Genes, L. Vaur, P. Clerson, B. Vaisse, J.-M. Mallion, and G. Chatellier
Is "Isolated Home" Hypertension as Opposed to "Isolated Office" Hypertension a Sign of Greater Cardiovascular Risk?
Arch Intern Med, October 8, 2001; 161(18): 2205 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
J. A Staessen, E. T O'Brien, L. Thijs, and R. H Fagard
Modern approaches to blood pressure measurement
Occup. Environ. Med., August 1, 2000; 57(8): 510 - 520.
[Abstract] [Full Text]


Home page
Nephrol Dial TransplantHome page
F. N. Ozdemir, G. Guz, S. Sezer, Z. Arat, and M. Haberal
Ambulatory blood pressure monitoring in potential renal transplant donors
Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1038 - 1040.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Parati, L. Ulian, L. Sampieri, P. Palatini, A. Villani, A. Vanasia, and G. Mancia
Attenuation of the "White-Coat Effect" by Antihypertensive Treatment and Regression of Target Organ Damage
Hypertension, February 1, 2000; 35(2): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Bellomo, P. L. Narducci, F. Rondoni, G. Pastorelli, G. Stangoni, G. Angeli, and P. Verdecchia
Prognostic Value of 24-Hour Blood Pressure in Pregnancy
JAMA, October 20, 1999; 282(15): 1447 - 1452.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. B. MacDonald, G. P. Laing, M. P. Wilson, and T. W. Wilson
Prevalence and predictors of white-coat response in patients with treated hypertension
Can. Med. Assoc. J., August 1, 1999; 161(3): 265 - 269.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Owens, N. Atkins, and E. O'Brien
Diagnosis of White Coat Hypertension by Ambulatory Blood Pressure Monitoring
Hypertension, August 1, 1999; 34(2): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Khattar, R. Senior, and A. Lahiri
Cardiovascular Outcome in White-Coat Versus Sustained Mild Hypertension : A 10-Year Follow-Up Study
Circulation, November 3, 1998; 98(18): 1892 - 1897.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. W Muscholl, H.-W Hense, U. Bröckel, A. Döring, G. A J Riegger, and H. Schunkert
Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey
BMJ, August 29, 1998; 317(7158): 565 - 570.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Parati, L. Ulian, C. Santucciu, S. Omboni, and G. Mancia
Difference Between Clinic and Daytime Blood Pressure Is Not a Measure of the White Coat Effect
Hypertension, May 1, 1998; 31(5): 1185 - 1189.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Lantelme, H. Milon, C. Gharib, C. Gayet, and J.-O. Fortrat
White Coat Effect and Reactivity to Stress : Cardiovascular and Autonomic Nervous System Responses
Hypertension, April 1, 1998; 31(4): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C R GIBBS, S MURRAY, and D G BEEVERS
The clinical value of ambulatory blood pressure monitoring
Heart, February 1, 1998; 79(2): 115 - 117.
[Full Text]


Home page
HypertensionHome page
S. D. Pierdomenico, F. Costantini, A. Bucci, D. De Cesare, F. Cuccurullo, and A. Mezzetti
Low-Density Lipoprotein Oxidation and Vitamins E and C in Sustained and White-Coat Hypertension
Hypertension, February 1, 1998; 31(2): 621 - 626.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Palatini, P. Mormino, M. Santonastaso, L. Mos, M. Dal Follo, G. Zanata, and A. C. Pessina
Target-Organ Damage in Stage I Hypertensive Subjects With White Coat and Sustained Hypertension: Results From the HARVEST Study
Hypertension, January 1, 1998; 31(1): 57 - 63.
[Abstract] [Full Text]


Home page
JAMAHome page
J. A. Staessen, G. Byttebier, F. Buntinx, H. Celis, E. T. O'Brien, and R. Fagard
Antihypertensive Treatment Based on Conventional or Ambulatory Blood Pressure Measurement: A Randomized Controlled Trial
JAMA, October 1, 1997; 278(13): 1065 - 1072.
[Abstract] [PDF]


Home page
HypertensionHome page
N.-C. Chang, Z.-Y. Lai, P. Chan, and T.-C. Wang
Left Ventricular Filling Profiles in Young White-Coat Hypertensive Patients Without Hypertrophy
Hypertension, September 1, 1997; 30(3): 746 - 752.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, and C. Porcellati
Prognostic Significance of the White Coat Effect
Hypertension, June 1, 1997; 29(6): 1218 - 1224.
[Abstract] [Full Text]


Home page
BMJHome page
N. Prasad and C. Isles
Fortnightly Review: Ambulatory blood pressure monitoring: a guide for general practitioners
BMJ, December 14, 1996; 313(7071): 1535 - 1541.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, T. Miyata, and K. Shimada
Factor VII Hyperactivity and Endothelial Cell Damage Are Found in Elderly Hypertensives Only When Concomitant With Microalbuminuria
Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 455 - 461.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. D. Pierdomenico, D. Lapenna, M. D. Guglielmi, T. Antidormi, C. Schiavone, F. Cuccurullo, and A. Mezzetti
Target Organ Status and Serum Lipids in Patients With White Coat Hypertension
Hypertension, November 1, 1995; 26(5): 801 - 807.
[Abstract] [Full Text]